Serotonergic functioning correlates with positive and negative affect in psychiatrically healthy males

Personality and Individual Differences

Volumn 30, Issue 1, 2001, Pages 71-86

  Zalda, David H ^a   Depue, Richard A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Affect; Emotion; Lability; Personality; Serotonin; Temperament

Indexed keywords

EID: 0035808720     PISSN: 01918869     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0191-8869(00)00011-8     Document Type: Article

References (70)

1. Albinsson, A., Palazidou, E., Stephenson, J., & Andersson, G. (1994). Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. European Journal of Pharmacology, 251, 157-161.
2. Ball, D., Hill, L., Freeman, B., Eley, T. C., Strelau, J., Riemann, R., Spinath, F. M., Angleitner, A., & Plomin, R. (1997). The serotonin transporter gene and peer-rated neurotocism. Neuroreport, 8, 1301-1304.
3. Ben-Jonathon, N. (1985). Dopamine: a prolactin-inhibiting hormone. Endocrine Reviews, 6, 564-589.
4. Brewerton, T. (1989). Seasonal variation of serotonin functions in humans: research and clinical implications. Psychiatry Research, 1, 153-164.
5. Cleare, A. J., & Bond, A. J. (1997). Does central serotonergic function correlate inversely with aggression A study using D-fenfluramine in healthy subjects? Psychiatry Research, 69, 89-95.
6. Coccaro, E. F., & Kavoussi, R. J. (1996). Neurotransmitter correlates of aggression. In D. M. Stoff, & R. B. Cairns, The neurobiology of clinical aggression (pp. 67-85). Mahwah, NJ: Erlbaum Associates Inc.
7. Coccaro, E. F., Kavoussi, R. J., Cooper, T. B., & Hauger, R. L. (1996a). Hormonal responses to d-and d,1-fenfluramine in healthy human subjects. Neuropsychopharmacology, 15, 595-607.
8. Coccaro, E. F., Kavoussi, R. J., Cooper, T. B., & Hauger, R. L. (1997). Central serotonin activity and aggression - inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. American Journal of Psychiatry, 154, 1430-1435.
9. Coccaro, E. F., Kavoussi, R. J., Oakes, M., Cooper, T. B., & Hauger, R. (1996b). 5-HT2a/2c, receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in psychiatrically healthy human subjects. Psychopharmacology, 126, 24-30.
10. Coccaro, E. F., Siever, L. J., Klar, H., Maurer, G., Cochrane, K., Cooper, T. B., Mohs, R. C., & Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry, 46, 567-599.
11. Cooper, C., & McConville, C. (1990). Interpreting mood scores: clinical implications of individual differences in mood variability. British Journal of Medical Psychology, 63, 215-225.
12. Depue, R. A. (1995). Neurobiological factors in personality and depression. European Journal of Personality, 9, 413-439.
13. Depue, R., & Collins, P. (1999). Neurobiology and the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behavioral and Brain Sciences, 22, 491-569.
14. Depue, R. A., & Iacono, W. G. (1989). Neurobehavioral aspects of affective disorders. Annual Review of Psychology, 40, 457-492.
15. Depue, R., Luciana, M., Arbisi, P., Collins, P., & Leon, A. (1994). Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. Journal of Personality and Social Psychology, 67, 485-498.
16. Depue, R., & Spoont, M. R. (1986). Conceptualizing a serotonin trait: a behavioral dimension of constraint. Annals of the New York Academy of Sciences, 487, 47-62.
17. Depue, R., & Zald, D. H. (1993). Biological and environmental processes in nonpsychotic psychopathology. In C. Costello, Basic issues in psychopathology (pp. 127-237). New York: Guilford Press.
18. Ebstein, R. P., Gritsenko, I., Nemanov, L., Frisch, A., Osher, Y., & Belmaker, R. H. (1997a). No association between the serotonin transporter gene regulatory region polymorphism and the tridimensional personality questionnaire (TPQ) temperament of harm avoidance. Molecular Psychiatry, 2, 224-226.
19. Ebstein, R. P., Segman, R., Benjamin, J., Osher, Y., Nemanov, L., & Belmaker, R. H. (1997b). 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 (D4DR) and dopamine D3 (D3DR) polymorphisms. American Journal of Medical Genetics, 74, 65-72.
20. Feeney, S., Goodall, E., & Silverstone, T. (1993). The prolactin response to d-and 1-fenfluramine and to d-amphetamine in human subjects. International Clinical Psychopharmacology, 8, 49-54.
21. Flory, J. D., Manuck, S. B., Ferrell, R. E., Dent, K. M., Peters, D. G., & Muldoon, M. F. (1999). Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Molecular Psychiatry, 4, 93-96.
22. Gelernter, J., Kranzler, H., Coccaro, E. F., Siever, L. J., & New, A. S. (1998). Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. American Journal of Psychiatry, 155, 1332-1338.
23. Goddard, A., Charney, D. S., Germine, M., Wood, S., Henninger, G., Krystal, J. H., Goodman, W. K., & Price, L. H. (1995). Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biological Psychiatry, 38, 74-85.
24. Goodall, E., Cowen, P. J., Franklin, M., & Silverstone, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology, 112, 461-466.
25. Graeff, F. G. (1984). The anti-aversive action of minor tranquilizers. Trends in Pharmacological Sciences, 6, 230-233.
26. Gray, J. (1982). The neuropsychology of anxiety. New York: Oxford Press.
27. Hepburn, L., & Eysenck, H. (1989). Personality, average mood and variability. Personality and Individual Differences, 10, 975-983.
28. Herve, D., Simon, H., Blanc, G., Le Moal, M., Glowinski, J., & Tassin, J. (1981). Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat. Brain Research, 216, 422-428.
29. Jorm, A. F., Henderson, A. S., Jacomb, P. A., Christensen, H., Korten, A. E., Rodgers, B., Tan, X., & Easteal, S. (1998). An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Molecular Psychiatry, 3, 449-451.
30. Josimovich, J. B., Lavenhar, M. A., Devanesan, M. M., Sesta, H. J., Wilchins, S. A., & Smith, A. C. (1987). Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication. Fertility and Sterility, 47, 785-791.
31. Kardum, I. (1999). Affect intensity and frequency: their relation to mean level and variability of positive and negative affect and Eysenck's personality traits. Personality and Individual Differences, 26, 33-47.
32. Katsuragi, S., Kunugi, H., Sano, A., Tsutsumi, T., Isogawa, K., Nanko, S., & Akiyoshi, J. (1999). Association between serotonin transporter gene polymorphism and anxiety-related traits. Biological Psychiatry, 45, 368-370.
33. Kelland, M., & Chiodo, L. (1996). Serotonergic modulation of midbrain dopamine systems. In C. J. Ashby, The modulation of dopaminergic neurotransmission by other neurotransmitters (pp. 76-92). Boca Raton, Fl: CRC Press.
34. Knutson, B., Wolkowitz, O. M., Cole, S. W., Chan, T., Moore, E. A., Johnson, R. C., Terpstra, J., Turner, R. A., & Reus, V. I. (1998). Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry, 155, 373-379.
35. Kumakiri, C., Kodama, K., Shimizu, E., Yamanouchi, N., Okada, S., Noda, S., Okamoto, H., Sato, T., & Shirasawa, H. (1999). Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neuroscience Letters, 263, 205-207.
36. Larsen, R. J. (1987). The stability of mood variability: a spectral analytic approach to daily mood assessments. Journal of Personality and Social Psychology, 52, 1195-1204.
37. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., & Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527-1531.
38. Loh, E., & Roberts, D. (1990). Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology, 101, 262-266.
39. Lowy, M., & Meltzer, H. Y. (1988). Stimulation of serum cortisol and prolactin by MK-212, a centrally active serotonin antagonist. Biological Psychiatry, 23, 818-828.
40. Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218-226.
41. Lucki, I. (1992). 5-HT1 receptors and behavior. Neuroscience and Biobehavioral Reviews, 16, 83-93.
42. Manuck, S. B., Flory, J. D., McCaffery, J. M., Mathews, K. A., Mann, J. J., & Muldoon, M. F. (1998). Aggression, impulsivity and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology, 19, 287-299.
43. McConville, C., & Cooper, C. (1992). Mood variability and personality. Personality and Individual Differences, 13, 1213-1221.
44. Mitchell, P., & Smythe, G. A. (1991). Endocrine and amine responses to D,L-fenfluramine in normal subjects. Psychiatry Research, 39, 141-153.
45. Mueller, E., Sunderland, T., & Murphy, D. L. (1985). Neuroendocrine effects of m-CPP, a serotonin agonist in humans. Journal of Clinical Endocrinology and Metabolism, 61, 1179-1184.
46. Muldoon, M. F., Manuck, S. B., Jansma, C. L., Moore, A. L., Perel, J., & Mann, J. J. (1996). d,1-fenfluramine challenge test - experience in a nonpatient sample. Biological Psychiatry, 39, 761-768.
47. Murakami, F., Shimomura, T., Kotani, K., Ikawa, S., Nanba, E., & Adachi, K. (1999). Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. Journal of Human Genetics, 44, 15-17.
48. O'Keane, V., Moloney, E., O'Neill, H., O'Connor, A., Smith, C., & Dinna, T. (1992). Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. British Journal of Psychiatry, 160, 643-646.
49. O'Keane, V., O'Hanlon, M., Webb, M., & Dinan, T. (1991). d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clinical Endocrinology, 34, 289-292.
50. Panksepp, J. (1986). The anatomy of emotions. In E. Plutchik & H. Kellerman, Emotion: theory, research, and experience (pp. 91-124). In Biological foundations of emotion, Vol. 3. New York: Academic Press.
51. Pazos, A., Probst, A., & Palacios, J. M. (1987). Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience, 21, 97-122.
52. Pick, L. H., Halperin, J. M., Schwartz, S. T., & Newcorn, J. H. (1999). A longitudinal study of neurobiological mechanisms in boys with attention-deficit hyperactivity disorder: preliminary findings. Biological Psychiatry, 45, 371-373.
53. Quattrone, A., Tddeschi, G., Agugllia, U., Scopocasa, F., Direnzo, G., & Annuziato, L. (1983). Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurons. Studies with fenfluramine. British Journal of Clinical Pharmacology, 16, 471-475.
54. Rowland, N., & Carlton, J. (1986). Neurobiology of an anorectic drug: fenfluramine. Progress in Neurobiology, 27, 13-62.
55. Salzman, C., Wolfson, A., Schatzberg, A., Looper, J., Henke, R., Albanese, M., Schwartz, J., & Miyawaki, E. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15, 23-29.
56. Smith, S., Pihl, R., Young, S., & Ervin, F. (1985). A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology, 91, 451-457.
57. Soubrie, P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. The Behavioral and Brain Sciences, 9, 319-364.
58. Spitzer, R. L., Williams, J. B., Gibbon, M. & First, M. B. (1990). Structured clinical interview for DSM-III-R, Non-patient edition. Washington, DC: APA (Version 1.0).
59. Spoont, M. R. (1992). Modulatory role of serotonin in neural information processing: Implications for human psychopathology. Psychological Bulletin, 11, 350.
60. Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, D., Reid, R., Grover, D., & Streiner, D. (1995). Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/premenstrual dysphoria collaborative study group. New England Journal of Medicine, 332, 1529-1534.
61. Stoff, D., Pasatiempo, A., Yeung, J., Bridger, H., & Rabinovich, H. (1992). Test-retest reliability of the prolactin and cortisol responses to d, 1-fenfluramine challenge in disruptive behavior disorders. Psychiatry Research, 46, 72.
62. 2 antagonists on prolactin secretion. Neuropharmacology, 28, 299-305.
63. Van Vliet, I. M., Den Boer, J. A., & Westenberg, H. G. (1994). Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology, 115, 128-134.
64. Watson, D., & Clark, L. (1992). Affects separable and inseparable: on the hierarchical arrangement of the negative affects. Journal of Personality and Social Psychology, 62, 489-505.
65. Watson, D., Clark, L., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. Journal of Personality and Social Psychology, 54, 1063-1070.
66. Watson, D., & Tellegen, A. (1985). Toward a consensual structure of mood. Psychological Bulletin, 92, 426-457.
67. Young, S., Smith, S., Pihl, R., & Ervin, F. (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology, 87, 173-177.
68. Zald, D. H. (1997). Serotonergic influences on self-reported affect: A d,1-fenfluramine challenge study. Unpublished Dissertation. University of Minnesota, Minneapolis, Minnesota
69. Zevon, M., & Tellegen, A. (1982). The structure of mood change. An idiographic/nomothetic analysis. Journal of Personality and Social Psychology, 43, 11-122.
70. Zuckerman, > M. (1991). Pschobiology of personality. New York: Cambridge University Press.